One of the cleavages found selective for MMP-2 occurs in SERPINE2, a broad serine protease inhibitor, whose polymorphism is known to be a risk-mitigating factor in COPD [44]. This evidence concerns the gene SERPINE2 and chronic obstructive pulmonary disease.